Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
993
total citations
- FWCI
- 67.74
- Percentile
- 100%
- References
- 37
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Telmisartan
- Medicine
- Placebo
- Stroke (engine)
- Hazard ratio
- Internal medicine
- Myocardial infarction
- Diabetes mellitus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.